| abstract |
The present invention relates to sulphonamide derivatives corresponding to the general formula (I), in which Ar1 represents an aryl optionally substituted with one or more groups, or an optionally substituted heterocyclyl group; T represents a -(CH2)n- or a group (II), Ar2 represents an aryl as optionally substituted with one or more groups, or an optionally substituted heterocyclyl group; Ar3 represents an aryl optionally substituted with one or more groups, or else an optionally substituted heterocyclyl, R1 represents a group of formula (A) or (B): (A) (B) in the form of a base, an addition salt with an acid, a hydrate or a solvate, in the form of enantiomers, diastereoisomers, rotamers or atropoisomers, or mixtures thereof. It also relates to the process for the preparation and also the therapeutic use of the compounds of formula (I). |